Optimi Health Corp. (CNSX: OPTI)
Health Care · Pharmaceuticals · CA
CA$5.70
-10.94% today · -47.2% 1Y
Optimi Health Corp. (CNSX: OPTI) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $22.87M and employs 9 people.
Over the last twelve months the share price has lost 47.2%, trading between 5.65 and 12.60.
Tweenvest scores Optimi Health Corp. across four factors: quality 40/100, value 56/100. Its strongest factor is value.
OPTI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $22.87M
- Revenue (TTM)
- $123.70K
- P/E
- —
- EPS
- -1.98
- Dividend yield
- —
- Beta (5Y)
- 1.57
- 52-week high
- CA$12.60
- 52-week low
- CA$5.65
- Avg volume (3M)
- —
- Shares outstanding
- 5.73M
- Employees
- 9
- Next earnings
- —
About Optimi Health Corp.
Optimi Health Corp. focuses on developing an integrated brand of functional mushrooms specifically for the Canadian health and wellness food markets. The company manages the entire process from the cultivation and extraction to the processing and distribution of these mushroom strains. Among the fungi varieties it offers are Lions Mane, Reishi, Turkey Tail, Chaga, and Cordyceps. Incorporated in 2020, the company was initially known as 1251418 BC Ltd. before officially changing its name to Optimi Health Corp. in August of that year. Its operations are headquartered in Vancouver, Canada.
- ISIN
- CA68405H3080
- Founded
- 2020
- Listed since
- Feb 25, 2021
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Kontafarma China Holdings LimitedSEHK: 1312 | $23.50M | HK$0.03 | +3.13% |
| Tdspharm Co., Ltd.KOSDAQ: A464280 | $22.99M | ₩5,590.00 | +3.71% |
| BCWORLD PHARM. Co., Ltd.KOSDAQ: A200780 | $22.96M | ₩3,020.00 | -0.98% |
| Sanjivani Paranteral LimitedBSE: 531569 | $22.88M | Rs180.25 | +9.18% |
| Provectus Biopharmaceuticals, Inc.OTCPK: PVCT | $22.23M | $0.05 | -2.76% |
| Sat Kartar Life LimitedNSEI: SATKARTAR | $22.22M | Rs136.60 | -25.80% |
| Neurothera Labs Inc.TSXV: NTLX | $22.17M | CA$2.30 | -47.73% |
| Aytu BioPharma, Inc.NasdaqCM: AYTU | $22.01M | $2.00 | -1.23% |
Figures last refreshed Oct 11, 2026.